Phibro Animal Health (NASDAQ:PAHC) Rating Increased to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research note published on Tuesday.

PAHC has been the topic of a number of other reports. Bank of America upped their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. Finally, Barclays boosted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $16.50.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $24.46 on Tuesday. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The company’s 50-day moving average price is $22.79 and its 200 day moving average price is $19.69. Phibro Animal Health has a 52 week low of $9.49 and a 52 week high of $25.98. The stock has a market cap of $990.63 million, a price-to-earnings ratio of 56.89, a PEG ratio of 0.66 and a beta of 0.51.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The business had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. As a group, research analysts forecast that Phibro Animal Health will post 1.59 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.96%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

Insider Buying and Selling at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The shares were purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the acquisition, the director now owns 25,000 shares of the company’s stock, valued at approximately $500,500. This represents a 25.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 50.07% of the stock is owned by company insiders.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently made changes to their positions in PAHC. Sofinnova Investments Inc. purchased a new stake in Phibro Animal Health during the 2nd quarter worth $3,975,000. American Century Companies Inc. grew its stake in shares of Phibro Animal Health by 119.6% in the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after buying an additional 189,068 shares in the last quarter. Acadian Asset Management LLC raised its holdings in shares of Phibro Animal Health by 32.8% during the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock valued at $8,726,000 after buying an additional 166,776 shares during the period. Jacobs Levy Equity Management Inc. lifted its position in Phibro Animal Health by 116.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock worth $4,330,000 after acquiring an additional 103,491 shares in the last quarter. Finally, Dana Investment Advisors Inc. boosted its holdings in Phibro Animal Health by 17.2% in the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.